Home › Targets › CDK2

CDK2 (2 companies · 2 programs)

Companies with an active program directed at CDK2.

Kymera Therapeutics, Inc. KYMR

KT-200 Preclinical

Monte Rosa Therapeutics, Inc. GLUE

CDK2 molecular glue degrader — Breast Cancer Preclinical